Gautam Jayram, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Bristol Myers Squibb
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Photocure
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Blue Earth
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Tempus
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    UroGPO
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    AstraZeneca
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Exact Sciences
    Date added:
    Date updated:
    06/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Merck
    Date added:
    Date updated:
    06/21/2023
Return to Operationalizing Checkpoint Inhibitors in Urologic Practice Webcast (2022)